ロード中...
Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
A major challenge in the management of antiretroviral therapy (ART) is to improve the patient’s adherence, reducing the burden caused by the high number of drugs that compose the treatment regimens for human immunodeficiency virus positive (HIV+) patients. Selection of the most appropriate treatment...
保存先:
| 出版年: | Biomedicines |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8003312/ https://ncbi.nlm.nih.gov/pubmed/33803812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9030313 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|